Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Inventory Summary of Telesis Bio, Inc.

  • Telesis Bio, Inc.'s latest annual inventory in 2023 was 4.02 Million USD , up 82.95% from previous year.
  • Telesis Bio, Inc.'s latest quarterly inventory in 2024 Q1 was 3.66 Million USD , down -8.84% from previous quarter.
  • Telesis Bio, Inc. reported annual inventory of 2.2 Million USD in 2022, down -7.09% from previous year.
  • Telesis Bio, Inc. reported annual inventory of 2.36 Million USD in 2021, up 294.01% from previous year.
  • Telesis Bio, Inc. reported quarterly inventory of 3.66 Million USD for 2024 Q1, down -8.84% from previous quarter.
  • Telesis Bio, Inc. reported quarterly inventory of 2.29 Million USD for 2023 Q1, up 4.27% from previous quarter.

Annual Inventory Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Inventory of Telesis Bio, Inc. (2023 - 2016)

Year Inventory Inventory Growth
2023 4.02 Million USD 82.95%
2022 2.2 Million USD -7.09%
2021 2.36 Million USD 294.01%
2020 601 Thousand USD -15.59%
2019 712 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Inventory Comparison of Telesis Bio, Inc.

Name Inventory Inventory Difference
Acutus Medical, Inc. 4.27 Million USD 5.914%
Biotricity, Inc. 1.87 Million USD -114.164%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 5.59 Million USD 28.048%
Nemaura Medical Inc. 1.75 Million USD -129.364%
PetVivo Holdings, Inc. 390.07 Thousand USD -931.85%
RetinalGenix Technologies Inc. - USD -Infinity%
Sonendo, Inc. 11.07 Million USD 63.654%
Talis Biomedical Corporation - USD -Infinity%
Viveve Medical, Inc. 1.47 Million USD -173.438%